HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy.

Abstract
Arrhythmogenic right ventricular cardiomyopathy (ARVD/C) is a genetically heterogeneous disease characterized by progressive degeneration of the right ventricular myocardium and increased risk of sudden death. Here, we report on a genome scan in one Italian family in which the disease appeared unlinked to any of the six different ARVD loci reported so far; we identify a mutation (S299R) in exon 7 of desmoplakin (DSP), which modifies a putative phosphorylation site in the N-terminal domain binding plakoglobin. It is interesting that a nonsense DSP mutation was reported elsewhere in the literature, inherited as a recessive trait and causing a biventricular dilative cardiomyopathy associated with palmoplantar keratoderma and woolly hairs. Therefore, different DSP mutations might produce different clinical phenotypes, with different modes of inheritance.
AuthorsAlessandra Rampazzo, Andrea Nava, Sandro Malacrida, Giorgia Beffagna, Barbara Bauce, Valeria Rossi, Rosanna Zimbello, Barbara Simionati, Cristina Basso, Gaetano Thiene, Jeffrey A Towbin, Gian A Danieli
JournalAmerican journal of human genetics (Am J Hum Genet) Vol. 71 Issue 5 Pg. 1200-6 (Nov 2002) ISSN: 0002-9297 [Print] United States
PMID12373648 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Cytoskeletal Proteins
  • DSP protein, human
  • Desmoplakins
  • Genetic Markers
  • gamma Catenin
Topics
  • Adolescent
  • Aged
  • Amino Acid Sequence
  • Arrhythmogenic Right Ventricular Dysplasia (genetics)
  • Cytoskeletal Proteins (genetics, metabolism)
  • Desmoplakins
  • Female
  • Genes, Dominant
  • Genetic Markers
  • Humans
  • Male
  • Molecular Sequence Data
  • Pedigree
  • Point Mutation
  • gamma Catenin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: